Alembic Pharma proposes to consider buyback of equity shares, in a meeting of buyback committee scheduled to be held on March 12.

The board will consider the buyback price and the number of equity shares to be bought back by the company. As per Regulation 9 of Securities and Exchange Board of India (Buy Back of Securities) Regulations, 1998, they will also fix the record date, to determine the equity shareholders of the company who shall be eligible to participate in the buy-back offer.

Furthermore, for prevention of insider trading, the trading window will be closed from March 8 to March 14,2018.

Read EquityPandit’s Technical Analysis of Nifty Pharma Outlook for the Week